United Therapeutics | UTHR - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Amarin USD 612.88M 10.12M 2026-09
Ardelyx USD 381.87M 447K 2026-03
Baxter International USD 6.83B 163M 2026-09
Bayer EUR 33.64B 1.66B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 56.35B 3.42B 2026-09
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Moderna USD 5.82B 45M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 41.36B 1.46B 2026-06
PTC Therapeutics USD 2.54B 79.58M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06